Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 372

1.

An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN).

Tauziède-Espariat A, Debily MA, Castel D, Grill J, Puget S, Sabel M, Blomgren K, Gareton A, Dangouloff-Ros V, Lechapt E, Boddaert N, Varlet P.

Acta Neuropathol Commun. 2019 Jun 10;7(1):10. doi: 10.1186/s40478-019-0738-y. No abstract available.

2.

Risk factors for in-brain local progression in elderly patients after resection of cerebral metastases.

Munoz-Bendix C, Rapp M, Mijderwijk HJ, von Sass C, Dibué-Adjei M, Cornelius JF, Steiger HJ, Turowski B, Sabel M, Kamp MA.

Sci Rep. 2019 May 15;9(1):7431. doi: 10.1038/s41598-019-43942-9.

3.

Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis.

Körber V, Yang J, Barah P, Wu Y, Stichel D, Gu Z, Fletcher MNC, Jones D, Hentschel B, Lamszus K, Tonn JC, Schackert G, Sabel M, Felsberg J, Zacher A, Kaulich K, Hübschmann D, Herold-Mende C, von Deimling A, Weller M, Radlwimmer B, Schlesner M, Reifenberger G, Höfer T, Lichter P.

Cancer Cell. 2019 Apr 15;35(4):692-704.e12. doi: 10.1016/j.ccell.2019.02.007. Epub 2019 Mar 21.

PMID:
30905762
4.

Determination of optimal time window for cortical mapping in awake craniotomy: assessment of intraoperative reaction speed.

Meskelevicius D, Schäfer A, Weber JK, Hegmann L, Haddad L, Kamp MA, Mainzer B, Rapp M, Steiger HJ, Sabel M.

Neurosurg Rev. 2019 Mar 15. doi: 10.1007/s10143-019-01094-4. [Epub ahead of print]

PMID:
30877481
5.

Treatment-related uptake of O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-3H]-methionine after tumor resection in rat glioma models.

Geisler S, Stegmayr C, Niemietz N, Lohmann P, Rapp M, Stoffels G, Willuweit A, Galldiks N, Filss CP, Sabel M, Coenen HH, Shah NJ, Langen KJ.

J Nucl Med. 2019 Mar 8. pii: jnumed.119.225680. doi: 10.2967/jnumed.119.225680. [Epub ahead of print]

PMID:
30850492
6.

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.

Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society.

Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14.

PMID:
30782343
7.

Clinical Cancer Advances 2019: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

Pal SK, Miller MJ, Agarwal N, Chang SM, Chavez-MacGregor M, Cohen E, Cole S, Dale W, Magid Diefenbach CS, Disis ML, Dreicer R, Graham DL, Henry NL, Jones J, Keedy V, Klepin HD, Markham MJ, Mittendorf EA, Rodriguez-Galindo C, Sabel MS, Schilsky RL, Sznol M, Tap WD, Westin SN, Johnson BE.

J Clin Oncol. 2019 Apr 1;37(10):834-849. doi: 10.1200/JCO.18.02037. Epub 2019 Jan 31. No abstract available.

PMID:
30702028
8.

Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer.

Altan M, Kidwell KM, Pelekanou V, Carvajal-Hausdorf DE, Schalper KA, Toki MI, Thomas DG, Sabel MS, Hayes DF, Rimm DL.

NPJ Breast Cancer. 2018 Dec 10;4:40. doi: 10.1038/s41523-018-0095-1. eCollection 2018.

9.

Is 5-ALA fluorescence of cerebral metastases a prognostic factor for local recurrence and overall survival?

Kamp MA, Munoz-Bendix C, Mijderwijk HJ, Turowski B, Dibué-Adjei M, von Saß C, Cornelius JF, Steiger HJ, Rapp M, Sabel M.

J Neurooncol. 2019 Feb;141(3):547-553. doi: 10.1007/s11060-018-03066-y. Epub 2018 Dec 10.

PMID:
30535595
10.

Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.

Briel-Pump A, Beez T, Ebbert L, Remke M, Weinhold S, Sabel MC, Sorg RV.

J Photochem Photobiol B. 2018 Dec;189:298-305. doi: 10.1016/j.jphotobiol.2018.11.002. Epub 2018 Nov 7.

11.

Surgery of Small Anterior Skull Base Meningiomas by Endoscopic 5-Aminolevulinic Acid Fluorescence Guidance: First Clinical Experience.

Cornelius JF, Kamp MA, Tortora A, Knipps J, Krause-Molle Z, Beez T, Petridis AK, Sabel M, Schipper J, Steiger HJ.

World Neurosurg. 2019 Feb;122:e890-e895. doi: 10.1016/j.wneu.2018.10.171. Epub 2018 Nov 10.

PMID:
30419399
12.

Molecular determinants of post-mastectomy breast cancer recurrence.

Keene KS, King T, Hwang ES, Peng B, McGuire KP, Tapia C, Zhang H, Bae S, Nakhlis F, Klauber-Demore N, Meszoely I, Sabel MS, Willey SC, Eterovic AK, Hudis C, Wolff AC, De Los Santos J, Thompson A, Mills GB, Meric-Bernstam F.

NPJ Breast Cancer. 2018 Oct 12;4:34. doi: 10.1038/s41523-018-0089-z. eCollection 2018.

13.

The Impact of Education and Prescribing Guidelines on Opioid Prescribing for Breast and Melanoma Procedures.

Lee JS, Howard RA, Klueh MP, Englesbe MJ, Waljee JF, Brummett CM, Sabel MS, Dossett LA.

Ann Surg Oncol. 2019 Jan;26(1):17-24. doi: 10.1245/s10434-018-6772-3. Epub 2018 Sep 20.

PMID:
30238243
14.

Impact of distress screening algorithm for psycho-oncological needs in neurosurgical patients.

Rapp M, Schipmann S, Hoffmann K, Wiewrodt R, Steiger HJ, Kamp M, Stummer W, Wiewrodt D, Sabel M.

Oncotarget. 2018 Aug 3;9(60):31650-31663. doi: 10.18632/oncotarget.25833. eCollection 2018 Aug 3.

15.

Quantification of ALA-fluorescence induced by a modified commercially available head lamp and a surgical microscope.

Sabel M, Knipps J, Neumann LM, Kieslich M, Steiger HJ, Rapp M, Kamp MA.

Neurosurg Rev. 2018 Oct;41(4):1079-1083. doi: 10.1007/s10143-018-0997-2. Epub 2018 Jul 23. No abstract available.

PMID:
30039396
16.

Cell line-based xenograft mouse model of paediatric glioma stem cells mirrors the clinical course of the patient.

Larsson S, Wenger A, Dósa S, Sabel M, Kling T, Carén H.

Carcinogenesis. 2018 Oct 8;39(10):1304-1309. doi: 10.1093/carcin/bgy091.

17.

Pleomorphic Lobular Carcinoma In Situ: Imaging Features, Upgrade Rate, and Clinical Outcomes.

Savage JL, Jeffries DO, Noroozian M, Sabel MS, Jorns JM, Helvie MA.

AJR Am J Roentgenol. 2018 Aug;211(2):462-467. doi: 10.2214/AJR.17.19088. Epub 2018 Jun 12.

PMID:
29894223
18.

Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.

Schaub C, Kebir S, Junold N, Hattingen E, Schäfer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Niessen M, Mack F, Stuplich M, Tzaridis T, Bähr O, Kortmann RD, Schlegel U, Schmidt-Graf F, Rohde V, Braun C, Hänel M, Sabel M, Gerlach R, Krex D, Belka C, Vatter H, Proescholdt M, Herrlinger U, Glas M.

J Cancer Res Clin Oncol. 2018 Aug;144(8):1581-1589. doi: 10.1007/s00432-018-2671-z. Epub 2018 May 28.

PMID:
29808316
19.

Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer.

Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, Wei S, Zhao L, Vatan L, Wen B, Shu P, Sun D, Kleer C, Wicha M, Sabel M, Tao K, Wang G, Zou W.

Cell Metab. 2018 Jul 3;28(1):87-103.e6. doi: 10.1016/j.cmet.2018.04.022. Epub 2018 May 24.

PMID:
29805099
21.

Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study.

Jagsi R, Griffith KA, Bellon JR, Woodward WA, Horton JK, Ho A, Feng FY, Speers C, Overmoyer B, Sabel M, Schott AF, Pierce L; Translational Breast Cancer Research Consortium.

J Clin Oncol. 2018 May 1;36(13):1317-1322. doi: 10.1200/JCO.2017.77.2665. Epub 2018 Mar 20.

PMID:
29558281
22.

Is it all a matter of size? Impact of maximization of surgical resection in cerebral tumors.

Kamp MA, Dibué-Adjei M, Cornelius JF, Slotty PJ, Steiger HJ, Ahmadi SA, Rapp M, Sabel M.

Neurosurg Rev. 2018 Mar 20. doi: 10.1007/s10143-018-0963-z. [Epub ahead of print] Review.

PMID:
29556836
23.

Comparison of O-(2-18F-Fluoroethyl)-L-Tyrosine Positron Emission Tomography and Perfusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Patients with Progressive and Recurrent Glioma: A Hybrid Positron Emission Tomography/Magnetic Resonance Study.

Verger A, Filss CP, Lohmann P, Stoffels G, Sabel M, Wittsack HJ, Kops ER, Galldiks N, Fink GR, Shah NJ, Langen KJ.

World Neurosurg. 2018 May;113:e727-e737. doi: 10.1016/j.wneu.2018.02.139. Epub 2018 Mar 3.

PMID:
29510293
24.

Improving Breast Cancer Surgical Treatment Decision Making: The iCanDecide Randomized Clinical Trial.

Hawley ST, Li Y, An LC, Resnicow K, Janz NK, Sabel MS, Ward KC, Fagerlin A, Morrow M, Jagsi R, Hofer TP, Katz SJ.

J Clin Oncol. 2018 Mar 1;36(7):659-666. doi: 10.1200/JCO.2017.74.8442. Epub 2018 Jan 24.

25.

Correlation of psychooncological distress- screening and quality of life assessment in neurosurgical patients.

Hoffmann K, Kamp M, Steiger HJ, Sabel M, Rapp M.

Oncotarget. 2017 Nov 30;8(67):111396-111404. doi: 10.18632/oncotarget.22802. eCollection 2017 Dec 19.

26.

Predictors for a further local in-brain progression after re-craniotomy of locally recurrent cerebral metastases.

Kamp MA, Fischer I, Dibué-Adjei M, Munoz-Bendix C, Cornelius JF, Steiger HJ, Slotty PJ, Turowski B, Rapp M, Sabel M.

Neurosurg Rev. 2018 Jul;41(3):813-823. doi: 10.1007/s10143-017-0931-z. Epub 2017 Dec 20.

PMID:
29260342
27.

Symptomatic communicating hydrocephalus in a contemporary cohort of high grade glioma patients.

Beez T, Burgula S, Kamp M, Rapp M, Steiger HJ, Sabel M.

Br J Neurosurg. 2018 Feb;32(1):68-72. doi: 10.1080/02688697.2017.1380780. Epub 2017 Nov 21.

PMID:
29160137
28.

Study protocol: A Randomized Controlled Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool (iCanDecide).

Hawley ST, Li Y, Jeanpierre LA, Goodell S, Jagsi R, Ward KC, Sabel MS, Katz SJ.

Contemp Clin Trials Commun. 2017 Mar;5:123-132. doi: 10.1016/j.conctc.2017.02.001. Epub 2017 Feb 3.

29.

In reply: Management of thin melanoma.

Durham AB, Schwartz JL, Lowe L, Zhao L, Johnson AG, Harms KL, Bichakjian CK, Orsini AP, McLean SA, Bradford CR, Cohen MS, Johnson TM, Sabel MS, Wong SL.

J Surg Oncol. 2018 Mar;117(3):536. doi: 10.1002/jso.24858. Epub 2017 Nov 11. No abstract available.

30.

Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.

Schäfer N, Proescholdt M, Steinbach JP, Weyerbrock A, Hau P, Grauer O, Goldbrunner R, Friedrich F, Rohde V, Ringel F, Schlegel U, Sabel M, Ronellenfitsch MW, Uhl M, Grau S, Hänel M, Schnell O, Krex D, Vajkoczy P, Tabatabai G, Mack F, Schaub C, Tzaridis T, Nießen M, Kebir S, Leutgeb B, Urbach H, Belka C, Stummer W, Glas M, Herrlinger U.

Neuro Oncol. 2018 Jun 18;20(7):975-985. doi: 10.1093/neuonc/nox204.

31.

In vivo near-infrared imaging of ErbB2 expressing breast tumors with dual-axes confocal endomicroscopy using a targeted peptide.

Gao Z, Li G, Li X, Zhou J, Duan X, Chen J, Joshi BP, Kuick R, Khoury B, Thomas DG, Fields T, Sabel MS, Appelman HD, Zhou Q, Li H, Kozloff K, Wang TD.

Sci Rep. 2017 Oct 31;7(1):14404. doi: 10.1038/s41598-017-13735-z.

32.

5-ALA-Induced Fluorescence in Leptomeningeal Dissemination of Spinal Malignant Glioma.

Krause Molle Z, Gierga K, Turowski B, Steiger HJ, Cornelius JF, Rapp M, Sabel M, Kamp MA.

World Neurosurg. 2018 Feb;110:345-348. doi: 10.1016/j.wneu.2017.10.069. Epub 2017 Oct 21.

PMID:
29066318
33.

Comprehensive Analysis of Hypermutation in Human Cancer.

Campbell BB, Light N, Fabrizio D, Zatzman M, Fuligni F, de Borja R, Davidson S, Edwards M, Elvin JA, Hodel KP, Zahurancik WJ, Suo Z, Lipman T, Wimmer K, Kratz CP, Bowers DC, Laetsch TW, Dunn GP, Johanns TM, Grimmer MR, Smirnov IV, Larouche V, Samuel D, Bronsema A, Osborn M, Stearns D, Raman P, Cole KA, Storm PB, Yalon M, Opocher E, Mason G, Thomas GA, Sabel M, George B, Ziegler DS, Lindhorst S, Issai VM, Constantini S, Toledano H, Elhasid R, Farah R, Dvir R, Dirks P, Huang A, Galati MA, Chung J, Ramaswamy V, Irwin MS, Aronson M, Durno C, Taylor MD, Rechavi G, Maris JM, Bouffet E, Hawkins C, Costello JF, Meyn MS, Pursell ZF, Malkin D, Tabori U, Shlien A.

Cell. 2017 Nov 16;171(5):1042-1056.e10. doi: 10.1016/j.cell.2017.09.048. Epub 2017 Oct 19.

34.

Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.

Kessler T, Sahm F, Sadik A, Stichel D, Hertenstein A, Reifenberger G, Zacher A, Sabel M, Tabatabai G, Steinbach J, Sure U, Krex D, Grosu AL, Bewerunge-Hudler M, Jones D, Pfister SM, Weller M, Opitz C, Bendszus M, von Deimling A, Platten M, Wick W.

Neuro Oncol. 2018 Feb 19;20(3):367-379. doi: 10.1093/neuonc/nox160.

35.

Correction: A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.

Tomić TT, Olausson J, Wilzén A, Sabel M, Truvé K, Sjögren H, Dósa S, Tisell M, Lannering B, Enlund F, Martinsson T, Åman P, Abel F.

PLoS One. 2017 Sep 7;12(9):e0184715. doi: 10.1371/journal.pone.0184715. eCollection 2017.

36.

Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.

Felsberg J, Hentschel B, Kaulich K, Gramatzki D, Zacher A, Malzkorn B, Kamp M, Sabel M, Simon M, Westphal M, Schackert G, Tonn JC, Pietsch T, von Deimling A, Loeffler M, Reifenberger G, Weller M; German Glioma Network.

Clin Cancer Res. 2017 Nov 15;23(22):6846-6855. doi: 10.1158/1078-0432.CCR-17-0890. Epub 2017 Aug 29.

37.

Comparison of 18F-FET PET and perfusion-weighted MRI for glioma grading: a hybrid PET/MR study.

Verger A, Filss CP, Lohmann P, Stoffels G, Sabel M, Wittsack HJ, Kops ER, Galldiks N, Fink GR, Shah NJ, Langen KJ.

Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2257-2265. doi: 10.1007/s00259-017-3812-3. Epub 2017 Aug 22.

PMID:
28831534
38.

Surgeon and Radiation Oncologist Views on Omission of Adjuvant Radiotherapy for Older Women with Early-Stage Breast Cancer.

Shumway DA, Griffith KA, Sabel MS, Jones RD, Forstner JM, Bott-Kothari TL, Hawley ST, Jeruss J, Jagsi R.

Ann Surg Oncol. 2017 Nov;24(12):3518-3526. doi: 10.1245/s10434-017-6013-1. Epub 2017 Jul 26.

PMID:
28748445
39.

Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.

Miller P, Kidwell KM, Thomas D, Sabel M, Rae JM, Hayes DF, Hudson BI, El-Ashry D, Lippman ME.

Breast Cancer Res Treat. 2017 Nov;166(1):85-94. doi: 10.1007/s10549-017-4366-6. Epub 2017 Jul 17.

PMID:
28717852
40.

The natural history of thin melanoma and the utility of sentinel lymph node biopsy.

Durham AB, Schwartz JL, Lowe L, Zhao L, Johnson AG, Harms KL, Bichakjian CK, Orsini AP, McLean SA, Bradford CR, Cohen MS, Johnson TM, Sabel MS, Wong SL.

J Surg Oncol. 2017 Dec;116(8):1185-1192. doi: 10.1002/jso.24765. Epub 2017 Jul 17.

41.

Impact of neoadjuvant chemotherapy on surgical outcomes among patients with hormone receptor positive breast cancer.

Hage AN, Capriccioso C, Brennan J, Heiden B, Zheutlin A, Sabel MS.

J Surg Oncol. 2017 Nov;116(6):665-670. doi: 10.1002/jso.24721. Epub 2017 Jul 3.

42.

5-ALA fluorescence behavior of cerebral infectious and inflammatory disease.

Steinmann J, Rapp M, Turowski B, Steiger HJ, Cornelius JF, Sabel M, Kamp MA.

Neurosurg Rev. 2018 Jan;41(1):365-369. doi: 10.1007/s10143-017-0867-3. Epub 2017 Jun 7. No abstract available.

PMID:
28593397
43.

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters MWJM, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM.

N Engl J Med. 2017 Jun 8;376(23):2211-2222. doi: 10.1056/NEJMoa1613210.

44.

Space-Occupying Tumor Bed Cysts as a Complication of Modern Treatment for High-Grade Glioma.

Beez T, Burgula S, Kamp M, Rapp M, Steiger HJ, Sabel M.

World Neurosurg. 2017 Aug;104:509-515. doi: 10.1016/j.wneu.2017.05.019. Epub 2017 May 13.

PMID:
28512049
45.

Hypothermia after cranial irradiation protects neural progenitor cells in the subventricular zone but not in the hippocampus.

Sabel M, Kalm M, Björk-Eriksson T, Lannering B, Blomgren K.

Int J Radiat Biol. 2017 Aug;93(8):771-783. doi: 10.1080/09553002.2017.1321810. Epub 2017 May 24.

PMID:
28452566
46.

A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.

Tomić TT, Olausson J, Wilzén A, Sabel M, Truvé K, Sjögren H, Dósa S, Tisell M, Lannering B, Enlund F, Martinsson T, Åman P, Abel F.

PLoS One. 2017 Apr 27;12(4):e0175638. doi: 10.1371/journal.pone.0175638. eCollection 2017. Erratum in: PLoS One. 2017 Sep 7;12 (9):e0184715.

47.

Recurrence Pattern Analysis of Primary Glioblastoma.

Rapp M, Baernreuther J, Turowski B, Steiger HJ, Sabel M, Kamp MA.

World Neurosurg. 2017 Jul;103:733-740. doi: 10.1016/j.wneu.2017.04.053. Epub 2017 Apr 19.

PMID:
28434963
48.

Dorsal Muscle Attenuation May Predict Failure to Respond to Interleukin-2 Therapy in Metastatic Renal Cell Carcinoma.

Otemuyiwa B, Derstine BA, Zhang P, Wong SL, Sabel MS, Redman BG, Wang SC, Alva AS, Davenport MS.

Acad Radiol. 2017 Sep;24(9):1094-1100. doi: 10.1016/j.acra.2017.03.003. Epub 2017 Mar 22.

PMID:
28341412
49.

Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.

Gramatzki D, Kickingereder P, Hentschel B, Felsberg J, Herrlinger U, Schackert G, Tonn JC, Westphal M, Sabel M, Schlegel U, Wick W, Pietsch T, Reifenberger G, Loeffler M, Bendszus M, Weller M.

Neurology. 2017 Apr 11;88(15):1422-1430. doi: 10.1212/WNL.0000000000003809. Epub 2017 Mar 15.

50.

Frozen sections in patients undergoing breast conserving surgery at a single ambulatory surgical center: 5 year experience.

Jorns JM, Daignault S, Sabel MS, Myers JL, Wu AJ.

Eur J Surg Oncol. 2017 Jul;43(7):1273-1281. doi: 10.1016/j.ejso.2017.01.237. Epub 2017 Feb 6.

PMID:
28215733

Supplemental Content

Support Center